Author(s): Khoharo HK, Shaikh IA
Abstract Share this page
Abstract OBJECTIVE: To determine the resistance patterns of mycobacterium tuberculosis (MTB) isolates among category I and II patients of pulmonary tuberculosis. METHODS: This cross sectional study was conducted at the Department of Medicine, Liaquat University of Medical and Health Sciences Jamshoro, from November 2008 to September 2009. Patients were divided into category I and II. The sputa were collected, stained with Ziehl-Nielsen (Z-N) staining and ultimately inoculated on Lowenstein-Jensen (L-J) media for six weeks. Out of 890 pulmonary tuberculosis (PTB) patients, the growth was obtained in 285 cases. The Drug sensitivity testing (DST) for Isoniazid (INH), Rifampicin (RIF), Ethambutol (EMB) Pyrazinamide (PZA) and Streptomycin (SM) were performed. The data was analyzed on SPSS 10.0. A p-value of <0.05 was taken as significant. RESULT: Out of 285 cases, 176 (61.75\%) were male and 109 (38.24\%) female. The mean age was 37 +/- 19.90 years. The DST showed drug sensitive and drug resistant isolates in 80 (28.05\%) and 205 (71.92\%) cases respectively (p=0.001). The drug resistant tuberculosis (DR-TB) rates for individual drugs; INH, RIF, EMB, PZA and SM were 51,22\%, 15.4\%, 13.33\%, 9\%12, and 3.85\% respectively (p=0.03). The MDR-TB isolates were detected in 120 (42.10\%) cases, including 5 (5.88\%) in category I and 115 (57.50\%) in category II patients (p=0.0001). CONCLUSION: Drug resistant and multidrug resistant tuberculosis was observed mainly in category II patients. However, primary MDR was also observed in category I patients and reflects dissemination of MDR cases within the community.
This article was published in J Pak Med Assoc
and referenced in Mycobacterial Diseases